When a therapeutic target can be addressed by either a small-molecule drug or a biologic (antibody, bispecific, ADC), the 4-year extension of the pre-negotiation window creates a clear financial argument for the biologic format
Waghu, F
Traditional pain management approaches focus on symptom relief through hormonal suppression or NSAIDs, but these methods often fall short of addressing the underlying inflammatory cascade
Additionally, the development of bioaugmentation techniques, wherein specific microbial strains are introduced into contaminated environments, has proven to be a key advancement
Many patients report feeling more focused and in control of their eating habits, which supports steady and realistic weight loss when combined with healthy lifestyle changes
NYHA class IV was exclusion criteria in ELIXA, LEADER and SUSTAIN-6 trials